TY - JOUR T1 - Influence of electromagnetic radiation emitted by daily-use electronic devices on the Eyemate<sup>®</sup> system JF - medRxiv DO - 10.1101/19011692 SP - 19011692 AU - Azzurra Invernizzi AU - Shereif Haykal AU - Valeria Lo Faro AU - Vincenzo Pennisi AU - Lars Choritz Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/11/20/19011692.abstract N2 - Purpose Eyemate® is a system for the continual monitoring of intraocular pressure (IOP), comprised of an intraocular sensor, and a hand-held reader device. The eyemate®-IO sensor is surgically implanted in the eye during cataract surgery. Once implanted, the sensor communicates telemetrically with the hand-held device to activate and record IOP measurements. The aim of this study was to assess the possible influence of electromagnetic radiation emitted by daily-use electronic devices on the eyemate® IOP measurements.Methods The eyemate®-IO sensor was placed in a plastic bag, immersed in a sterile sodium chloride solution at 0.9% and placed in a water bath at 37°C. The antenna, connected to a laptop for recording the data, was positioned at a fixed distance of 1 cm from the sensor. Approximately two hours of “quasi-continuous” measurements was recorded for the baseline and for cordless phone, smart-phone and laptop. Repeated measures ANOVA was used to compare any possible differences between the baseline and the tested devices.Results For baseline measurements, the sensor maintained a steady-state. The same behavior was observed with the devices measurements during active and inactive states.Conclusion We found no evidence of signal drifts or fluctuations associated with the tested devices, thus showing a lack of electromagnetic interference with data transmission. Patients who already have the eyemate®-IO sensor implanted, or those considering it, can be informed that the electromagnetic radiation emitted by their daily-use electronic devices does not interfere with IOP measurements made by the eyemate®-IO sensor.Competing Interest StatementThe authors have declared no competing interest.Funding Statementhis project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grants agreement No. 661883 (EGRET cofund) and No.675033 (EGRET plus). The funding organizations had no role in the design, conduct, analysis, or publication of this research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata available under request. ER -